Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aytu BioScience, Inc.

1.11
+0.06005.71%
Post-market: 1.110.00000.00%17:15 EDT
Volume:30.96K
Turnover:33.40K
Market Cap:6.85M
PE:-0.58
High:1.11
Open:1.06
Low:1.05
Close:1.05
Loading ...
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Oct 13, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Aug 15, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 24, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 16, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 07, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 06, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 27, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 22, 2023

Major Issues Report

Form 8-K - Current report